Literature DB >> 17900928

Retrospective cohort mortality study of workers in a polymer production plant including a reference population of regional workers.

Robin C Leonard1, Kim H Kreckmann, Carine J Sakr, J Morel Symons.   

Abstract

PURPOSE: Based on previous reports of increased serum lipid levels in workers at a U.S. polymer manufacturing facility, the study objective was to investigate ischemic heart disease (IHD) mortality as well as a broad range of mortality causes for an occupational cohort at the facility.
METHODS: The cohort comprised 6,027 men and women who had worked at the facility between 1948 and 2002; these years delimit the mortality follow-up period. Standardized mortality ratios (SMR) were estimated to compare observed numbers of deaths to expected numbers derived from mortality rates for 3 reference populations: the U.S. population, the West Virginia state population, and an 8-state regional employee population from the same company.
RESULTS: Most SMR estimates based on U.S. and state populations were below 100. Comparison to the employee population also resulted in many SMR estimates at or near a no-effect level. Relative to the regional worker population, a nonsignificant elevation for IHD mortality was observed (SMR = 109, 95% confidence interval [CI]: 96, 124). Mortality associated with diabetes was significantly increased compared to the regional worker population (SMR = 197, 95% CI: 123, 298). A corresponding increase in the SMR for IHD and diabetes mortality was not detected for comparisons with the two general populations.
CONCLUSIONS: The results reported herein show little evidence of increased cause-specific mortality risks for workers at the plant. This study demonstrates the utility of comparing occupational cohorts with a similar worker reference population in order to reduce bias associated with the healthy worker effect.

Entities:  

Mesh:

Year:  2007        PMID: 17900928     DOI: 10.1016/j.annepidem.2007.06.011

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  43 in total

1.  Perfluorinated Chemicals as Emerging Environmental Threats to Kidney Health: A Scoping Review.

Authors:  John W Stanifer; Heather M Stapleton; Tomokazu Souma; Ashley Wittmer; Xinlu Zhao; L Ebony Boulware
Journal:  Clin J Am Soc Nephrol       Date:  2018-09-13       Impact factor: 8.237

2.  Changing interpretation of human health risks from perfluorinated compounds.

Authors:  Philippe Grandjean; Richard Clapp
Journal:  Public Health Rep       Date:  2014 Nov-Dec       Impact factor: 2.792

3.  Per- and Polyfluoroalkyl Substances and Obesity, Type 2 Diabetes and Non-alcoholic Fatty Liver Disease: A Review of Epidemiologic Findings.

Authors:  Weipeng Qi; John M Clark; Alicia R Timme-Laragy; Yeonhwa Park
Journal:  Toxicol Environ Chem       Date:  2020-05-22       Impact factor: 1.437

Review 4.  Perfluorinated compounds: emerging POPs with potential immunotoxicity.

Authors:  Emanuela Corsini; Robert W Luebke; Dori R Germolec; Jamie C DeWitt
Journal:  Toxicol Lett       Date:  2014-02-03       Impact factor: 4.372

5.  Effect of long- and short-chain perfluorinated compounds on cultured thyroid cells viability and response to TSH.

Authors:  L Croce; F Coperchini; M Tonacchera; M Imbriani; M Rotondi; L Chiovato
Journal:  J Endocrinol Invest       Date:  2019-05-17       Impact factor: 4.256

Review 6.  Recent developments in polyfluoroalkyl compounds research: a focus on human/environmental health impact, suggested substitutes and removal strategies.

Authors:  John Baptist Nzukizi Mudumbi; Seteno Karabo Obed Ntwampe; Tandi Matsha; Lukhanyo Mekuto; Elie Fereche Itoba-Tombo
Journal:  Environ Monit Assess       Date:  2017-07-18       Impact factor: 2.513

Review 7.  Breast cancer and persistent organic pollutants (excluding DDT): a systematic literature review.

Authors:  Tafzila Akter Mouly; Leisa-Maree Leontjew Toms
Journal:  Environ Sci Pollut Res Int       Date:  2016-09-15       Impact factor: 4.223

8.  Association of perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS) with uric acid among adults with elevated community exposure to PFOA.

Authors:  Kyle Steenland; Sarah Tinker; Anoop Shankar; Alan Ducatman
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

Review 9.  Epidemiologic evidence on the health effects of perfluorooctanoic acid (PFOA).

Authors:  Kyle Steenland; Tony Fletcher; David A Savitz
Journal:  Environ Health Perspect       Date:  2010-04-27       Impact factor: 9.031

10.  Predictors of PFOA levels in a community surrounding a chemical plant.

Authors:  Kyle Steenland; Chuangfang Jin; Jessica MacNeil; Cathy Lally; Alan Ducatman; Veronica Vieira; Tony Fletcher
Journal:  Environ Health Perspect       Date:  2009-03-23       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.